Published in Br J Cancer on August 25, 2009
Merkel cell carcinoma: a population-based study on mortality and the association with other cancers. Cancer Causes Control (2011) 0.79
Associations between chronic diseases and choking deaths among older adults in the USA: a cross-sectional study using multiple cause mortality data from 2009 to 2013. BMJ Open (2015) 0.75
Kaposi Sarcoma in an Human Immunodeficiency Virus (HIV)-Seronegative Mediterranean Female: Report of a Rare Case. Am J Case Rep (2017) 0.75
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ (1987) 27.11
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06
Analytical potential for multiple cause-of-death data. Am J Epidemiol (1986) 3.46
Solid tumors after chronic lymphocytic leukemia. Blood (2001) 2.01
Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer (2009) 1.95
WHO case definitions for AIDS surveillance in adults and adolescents. Wkly Epidemiol Rec (1994) 1.79
Epidemiology of Kaposi's sarcoma in Sweden prior to the acquired immunodeficiency syndrome. Int J Cancer (1988) 1.41
Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer (2007) 1.40
Using multiple cause-of-death data to investigate associations and causality between conditions listed on the death certificate. Am J Epidemiol (2007) 1.31
Staging of classic Kaposi's sarcoma: a useful tool for therapeutic choices. Eur J Dermatol (2003) 1.26
Immunosenescence and immunogenetics of human longevity. Neuroimmunomodulation (2008) 1.19
Risk factors for classical Kaposi's sarcoma. J Natl Cancer Inst (2002) 1.18
Risk factors for classical Kaposi sarcoma in a population-based case-control study in Sicily. Cancer Epidemiol Biomarkers Prev (2008) 1.16
Birthplace and classic Kaposi's sarcoma in Italy. Associazione Italiana Registri Tumori. J Natl Cancer Inst (1995) 1.15
Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy. J Hum Virol (1999) 1.09
Mediterranean Kaposi's sarcoma in the elderly. A randomized study of oral etoposide versus vinblastine. Cancer (1994) 1.06
Classic Kaposi's sarcoma in Italy, 1985-1998. Br J Cancer (2005) 1.01
Risk of other cancers following Kaposi's sarcoma: relation to acquired immunodeficiency syndrome. Am J Epidemiol (1994) 0.99
Factors associated with reporting multiple causes of death. BMC Med Res Methodol (2005) 0.98
The bloodsucking arthropod bite as possible cofactor in the transmission of human herpesvirus-8 infection and in the expression of Kaposi's sarcoma disease. Parassitologia (2002) 0.94
Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission. Br J Cancer (2000) 0.94
Classic Kaposi's sarcoma as a second primary neoplasm. Int J Cancer (1999) 0.93
Classic Kaposi's sarcoma as a first primary neoplasm. Int J Cancer (1999) 0.92
Merkel cell carcinoma, Kaposi's sarcoma, basal cell carcinoma and keratoacanthoma: multiple association in a patient with chronic lymphatic leukaemia. Br J Dermatol (2002) 0.91
Human herpesvirus type 8 infection in an area of Northern Italy with high incidence of classical Kaposi's sarcoma. J Med Virol (2005) 0.91
Age-specific seroprevalence of Human Herpesvirus 8 in Mediterranean regions. Clin Microbiol Infect (2003) 0.87
Distribution of mosquito species in areas with high and low incidence of classic Kaposi's sarcoma and seroprevalence for HHV-8. Med Vet Entomol (2006) 0.86
Classic Kaposi Sarcoma in the United States over the last two decades: a clinicopathologic and molecular study of 438 non-HIV-related Kaposi Sarcoma patients with comparison to HIV-related Kaposi Sarcoma. Mod Pathol (2008) 0.84
Classical Kaposi's sarcoma: a survey of 163 cases observed in Bari, south Italy. Dermatology (1995) 0.84
Human herpesvirus 8-associated primary effusion lymphoma in HIV--patients: a clinicopidemiologic variant resembling classic Kaposi's sarcoma. Haematologica (2002) 0.83
Occurrence of primary cancers in association with multiple myeloma and Kaposi's sarcoma in the United States, 1973-1995. Int J Cancer (2000) 0.83
High incidence of classic Kaposi's sarcoma in Mantua, Po Valley, Northern Italy (1989-1998). Br J Cancer (2001) 0.82
A case of Kaposi's sarcoma following treatment of membranoproliferative glomerulonephritis and a review of the literature. Ren Fail (2007) 0.80
Classic Kaposi sarcoma. Which KSHV-seropositive individuals are at risk? Cancer (2006) 0.80
Risk of second cancers in classical Kaposi's sarcoma. Int J Cancer (1997) 0.79
Survival of classic Kaposi's sarcoma and risk of second cancer. Br J Cancer (1996) 0.77
Educational differences in smoking: international comparison. BMJ (2000) 4.56
Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings. Arch Gen Psychiatry (1998) 3.53
Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy. J Hepatol (1996) 2.19
Differences in self reported morbidity by educational level: a comparison of 11 western European countries. J Epidemiol Community Health (1998) 2.05
Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nat Biotechnol (2000) 1.79
Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat Biotechnol (1997) 1.75
Well-being therapy. A novel psychotherapeutic approach for residual symptoms of affective disorders. Psychol Med (1998) 1.62
Persistent variations in average height between countries and between socio-economic groups: an overview of 10 European countries. Ann Hum Biol (2000) 1.57
Impedance spectroscopy of solutions at physiological glucose concentrations. Biophys Chem (2007) 1.57
Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes. Nat Med (1998) 1.54
Gender differentials in life expectancy in Italy. Eur J Epidemiol (2003) 1.54
Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species. J Clin Microbiol (2002) 1.51
Yeast killer systems. Clin Microbiol Rev (1997) 1.47
Coronary risk factors and survival probability from coronary and other causes of death. Am J Epidemiol (1987) 1.46
Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies. J Immunol (1994) 1.42
Sevoflurane analgesia in obstetrics: a pilot study. Int J Obstet Anesth (2003) 1.38
Studies on the epidemiology of Aspergillus fumigatus infections in a university hospital. Eur J Epidemiol (1989) 1.29
Preparation and evaluation of release characteristics of 3TabGum, a novel chewing device. Eur J Pharm Sci (2005) 1.23
Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS (1994) 1.20
MIAMOD: a computer package to estimate chronic disease morbidity using mortality and survival data. Comput Methods Programs Biomed (1994) 1.13
Risk behaviors for HIV-1 infection in Italian drug users: report from a multicenter study. First Drug User Multicenter Study Group. J Acquir Immune Defic Syndr (1989) 1.09
Antibodies, killer toxins and antifungal immunoprotection: a lesson from nature? Immunol Today (1997) 1.07
Human natural yeast killer toxin-like candidacidal antibodies. J Immunol (1996) 1.07
Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies. Clin Diagn Lab Immunol (1997) 1.03
Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain. Br J Pharmacol (2003) 1.00
The risk of transfusion-transmitted HIV from blood donations of men who have sex with men, 12 months after last sex with a man: 2005-2007 estimates from England and Wales. Vox Sang (2013) 0.98
Estimation and projections of stomach cancer trends in Italy. Cancer Causes Control (1995) 0.97
Drinking pattern and mortality: the Italian Risk Factor and Life Expectancy pooling project. Ann Epidemiol (2001) 0.97
Drug use and HIV-1 infection: report from the Second Italian Multicenter Study. J Acquir Immune Defic Syndr (1991) 0.97
Stress proteins in fungal diseases. Med Mycol (1998) 0.97
Estimation and projections of colorectal cancer trends in Italy. Int J Epidemiol (1997) 0.97
Hepatitis B infections in the Arsi region of Ethiopia. Eur J Epidemiol (1988) 0.95
Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation. Health Technol Assess (2009) 0.95
Hepatitis B virus infection in Cameroon: a seroepidemiological survey in city school children. J Med Virol (1991) 0.95
Antibodies as crypts of antiinfective and antitumor peptides. Curr Med Chem (2009) 0.95
Idiotypic vaccination: immunoprotection mediated by anti-idiotypic antibodies with antibiotic activity. Scand J Immunol (1993) 0.94
Trends of colorectal cancer incidence and prevalence in Italian regions. Tumori (1998) 0.94
Heat-shock mannoproteins as targets of secretory IgA in Candida albicans. J Infect Dis (1994) 0.93
Hepatic artery ligation. Surgery (1979) 0.93
'Antibiobodies': antibiotic-like anti-idiotypic antibodies. J Med Vet Mycol (1991) 0.92
In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramycin. J Chemother (1995) 0.91
The potential for a concerted system for the rapid monitoring of excess mortality throughout Europe. Euro Surveill (2010) 0.90
Venous thromboembolism prophylaxis: a survey of its use in the United States. Arch Surg (1982) 0.89
Detection by immunofluorescent anti-idiotypic antibodies of yeast killer toxin cell wall receptors of Candida albicans. J Immunol Methods (1990) 0.89
In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. Oral Microbiol Immunol (2006) 0.89
Large-scale hormone replacement therapy and life expectancy: results from an international comparison among European and North American populations. Am J Public Health (2000) 0.89
Prediction of all causes of death as a function of some factors commonly measured in cardiovascular population surveys. Prev Med (1983) 0.88
Ethiopian National Hepatitis B Study. J Med Virol (1988) 0.86
Interfaces of the yeast killer phenomenon. Crit Rev Microbiol (1991) 0.86
New strategies in vaccination against fungal infections. J Med Vet Mycol (1994) 0.86
Splenic artery ligation for trauma. An alternative to splenectomy. Am J Surg (1980) 0.86
Long-term outcome of panic disorder with agoraphobia treated by exposure. Psychol Med (2001) 0.85
Postantibiotic leukocyte enhancement of meropenem against gram-positive and gram-negative strains. Antimicrob Agents Chemother (2000) 0.85
The VEPSY UPDATED Project: clinical rationale and technical approach. Cyberpsychol Behav (2003) 0.85
Six-month follow-up of in-patient experiential cognitive therapy for binge eating disorders. Cyberpsychol Behav (2003) 0.85
Mortality and morbidity after esophagogastrectomy for cancer of the esophagus and cardia. Am Surg (1977) 0.85
Mean levels and distributions of some cardiovascular risk factors in Italy in the 1970's and the 1980's. The Italian RIFLE Pooling Project. Risk factors and life expectancy. G Ital Cardiol (1995) 0.85
Surgical treatment of recurring preauricular sinus: supra-auricular approach. Acta Otorhinolaryngol Ital (2008) 0.85
Biotyping of bacterial isolates using the yeast killer system. Eur J Epidemiol (1989) 0.85
Coronary risk factors and excess mortality from all causes and specific causes. Int J Epidemiol (1983) 0.84
The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections. Med Mycol (2000) 0.84
Hansenula anomala killer toxin induces secretion and severe acute injury in the rat intestine. Gastroenterology (1995) 0.84
Protective antifungal yeast killer toxin-like antibodies. Curr Mol Med (2005) 0.83
Evaluation of the Abbott LCx Mycobacterium tuberculosis assay in comparison with culture methods in selected Italian patients. New Microbiol (1998) 0.83
Coronary risk factors predicting coronary and other causes of death in fifteen years. Acta Cardiol (1980) 0.83
Enzymic activities in dissociated neurons differentiated in cultures in vitro. J Neurochem (1973) 0.83
[Interregional mobility for total knee arthroplasty]. Ann Ig (2009) 0.83
Pharmacokinetics and pharmacodynamics of oral cephalosporins as critical factors in choice of antibiotics. Int J Antimicrob Agents (2000) 0.83
Is venous thromboembolism more frequent in patients with obstructive sleep apnea syndrome? J Thromb Haemost (2004) 0.82
Melatonin protects human red blood cells from oxidative hemolysis: new insights into the radical-scavenging activity. J Pineal Res (1999) 0.82
[Use of mortality statistics for the study of the distribution of digestive system tumors: characteristics and quality of the data]. Ann Ist Super Sanita (1996) 0.81
Abdominal aortic coarctation and pregnancy. J Cardiovasc Surg (Torino) (1980) 0.81
[Hepatitis B vaccination coverage and booster dose: results from a survey on healthcare students]. G Ital Med Lav Ergon (2013) 0.81
Engineered killer mimotopes: new synthetic peptides for antimicrobial therapy. Curr Med Chem (2004) 0.81
Structural and functional characterization of the porcine proline-rich antifungal peptide SP-B isolated from salivary gland granules. J Pept Sci (2008) 0.80
Reactivity of Candida albicans germ tubes with salivary secretory IgA. J Dent Res (1996) 0.80
Prevalence of hepatitis B infection among hospital personnel in Addis Ababa (Ethiopia). Eur J Epidemiol (1989) 0.80
The use of magnetic resonance imaging in posterior tibial tendon dysfunction. Clin Orthop Relat Res (1999) 0.79
Genital herpes infection in outpatients attending a sexually transmitted disease clinic in Italy. Eur J Epidemiol (1988) 0.79
Inhibitory effect of human natural yeast killer toxin-like candidacidal antibodies on Pneumocystis carinii. Mol Med (1997) 0.79
Clinical pharmacokinetics of meropenem after the first and tenth intramuscular administration. J Antimicrob Chemother (1996) 0.79
Oxidative stability and sensory and functional properties of eggs from laying hens fed supranutritional doses of vitamins E and C. Poult Sci (2002) 0.78
Regional differences in the motor and inflammatory responses to capsaicin in guinea pig airways. Correlation with content and release of substance P-like immunoreactivity. Am Rev Respir Dis (1989) 0.78
Influenza vaccination in patients on long-term anticoagulant therapy. Vaccine (2006) 0.78
In vitro candidacidal activity of a synthetic killer decapeptide (KP) against Candida albicans cells adhered to resin acrylic discs. J Oral Pathol Med (2007) 0.78
Use of yeast killer system to identify species of the Nocardia asteroides complex. J Clin Microbiol (1995) 0.78
Immunity to tetanus among Italians born between 1956 and 1963. Eur J Epidemiol (1987) 0.78
In vitro decrease of rat-derived Pneumocystis carinii attachment induced by human natural yeast killer toxin-like antiidiotypic candidacidal antibodies. J Eukaryot Microbiol (1996) 0.78
Recombinant Streptococcus gordonii for mucosal delivery of a scFv microbicidal antibody. Int Rev Immunol (2001) 0.78
Creutzfeldt-Jakob disease mortality in Italy, 1982-1996. Neuroepidemiology (1999) 0.78
An unanticipated role for survivin in organ transplant damage. Am J Transplant (2014) 0.78
Hepatitis C virus infection in households of anti-HCV chronic carriers in Italy: a multicentre case-control study. Infection (1998) 0.78
Ultrastructural localization of alkaline phosphatase in cultures of nervous tissue in vitro. J Neurocytol (1973) 0.77
Long-term outcome of social phobia treated by exposure. Psychol Med (2001) 0.77
Ultrastructural analysis and cholinesterase activity in the brain capillaries of Bufo bufo and Rana esculenta. J Hirnforsch (1987) 0.77
Newly-formed neurons in the regenerating optic tectum of Triturus cristatus carnifex. Basic Appl Histochem (1987) 0.77
[The use of municipality-level data on mortality in Italy: SENTIERI Project]. Epidemiol Prev (2011) 0.77
Preliminary study of the regenerative processes of the dorsal cortex of the telencephalon of Lacerta viridis. Z Mikrosk Anat Forsch (1977) 0.77
Effect of Pichia anomala killer toxin on Candida albicans. Med Mycol (1998) 0.77